Axial Spondyloarthritis Podcasts

In this first episode of our podcast series about Axial Spondyloarthritis (axSpA), Mel Brooke, Patient and Public Engagement Programme Director (BIRD) talks with Dr Raj Sengupta, Consultant Rheumatologist at the RNHRD (Bath) who explains about the various symptoms, diagnostic techniques and medications for this condition.

In the second episode of our podcast series about Axial Spondyloarthritis (axSpA), Mel Brooke, Patient and Public Engagement Programme Director (BIRD) invites Vicky Baldy, Senior Physiotherapist at the RNHRD and Brownsword Therapies Centre (Bath) to talk about the importance of staying active and how exercise is a really useful self-management tool for people with axSpA

In this third episode of our podcast series about Axial Spondyloarthritis (axSpA), Mel Brooke, Patient and Public Engagement Programme Director (BIRD) talks with Dr Elizabeth Reilly who shares some news about research projects she has been working on in 2020 and how the new virtual axSpA online course has been going. Dr Elizabeth Reilly is a Clinical Research Fellow in Rheumatologist at the RNHRD (Bath) and School of Pharmacy and Pharmacology, University of Bath.

In this fourth episode of our podcast series about Axial Spondyloarthritis (axSpA), Mel Brooke, Patient and Public Engagement Programme Director (BIRD) talks with Bath University researcher Rosie Barnett who talks about her work on Project Nightingale – an app developed to help people with axSpA self track symptoms and better manage their condition. For links mentioned in the podcast Rosies contact is rosiebarnett1@nhs.net or twitter @RosieBarnett95 and the website link is Project Nightingale

In the fifth and final episode of our podcast series about Axial Spondyloarthritis (axSpA), Mel Brooke, Patient and Public Engagement Programme Director (BIRD) invites Dr Dale Webb, Chief Executive of NASS (National Axial Spondyloarthritis Society) to share an update on the good works and campaigns of NASS during 2020 and what exciting plans they have for 2021.